ReviewDrug design, development and therapy2019
Quizartinib (AC220): a promising option for acute myeloid leukemia.
Fang Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
34 papers cite it
this papercites it
ReviewDrug design, development and therapy2019
Fang Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.